July 28, 2014
Cambridge, Massachusetts-based flexible electronics company MC10 has embarked on its first public partnership with a pharmaceutical company, Belgium-based UCB. Although many of the details remain undisclosed, the companies have announced that UCB will use MC10's BioStamp technology to pursue new therapies for neurological disorders.
"They’re going to combine our devices with their work to...
April 30, 2014
A team of researchers has found that, for 23 commonly used drugs, well over three times as many adverse drug reactions were reported on Twitter in a given time period than were reported to the FDA. Of course, the study also notes that the tweeted reports, referred to as "Proto AEs" (adverse events) weren't necessarily as specific or useful as FDA adverse event reports.
Over a six-month period,...
April 17, 2014
The Inspiromatic inhaler.
Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in "the low eight figures", according to Opko's Director of Strategic Investment Les Funtleyder. The company will be using Inspiro's Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and...
April 7, 2014
Patients want pharmaceutical companies to reach out to them through more digital channels, and to offer more value-add services, according to a new survey from Accenture of 2,000 American adults who are taking one or more medications and have a household income of $25,000 or more.
"Providing personalized and value-add services in support of the products they sell is common across almost every...
March 5, 2014
While increasing collaboration between payers and providers was a major theme at HIMSS in Orlando last week, one other major stakeholder has been quite a bit harder to find in conversations about big data, ACOs, and digital health. As Forbes columnist David Shaywitz wrote yesterday, pharma has been noticeably hesitant to jump into the fray.
At Merck however, a dedicated innovation group called...
January 21, 2014
A new report from IMS Health on the use of social media by pharmaceutical companies finds that among the top 50 pharmaceutical companies, half don't engage with consumers and patients through social media. But of those that do, IMS found that Johnson & Johnson emerged as a clear leader. It scored a 70 on IMS's Social Media Engagement Index. The next highest score, from GlaxoSmithkline, was...
July 1, 2013
A mobile app released last year by Pfizer.
A staggering 90 percent of chronic patients in the US would accept a mobile app prescription from their physician, as opposed to only 66 percent willing to accept a prescription of medication, according to a recent survey from health communications firm Digitas Health. Digitas presented preliminary research findings at a recent event in London, PMLiVE...
April 24, 2013
Treato, an Israeli company that scours thousands of social media sites to glean patient insights about pharmaceuticals and treatments, has landed $14.5 million in new capital. OrbiMed Israel Partners and New Leaf Venture Partners led the round of funding, which also included previous investors Reed Elsevier Ventures and Western Technology Investments, the company says.
Treato, of Yehud, Israel,...
April 23, 2013
Google's former Chief Health Strategist Roni Zeiger MD and Gilles Frydman, founder of the Association of Cancer Online Resources (ACOR), announced the launch of Smart Patients, a new online community for cancer patients and caregivers, at the TEDMED event in Washington DC last week.
"What we are primarily trying to do is help cancer patients and caregivers learn more effectively from each other...
October 30, 2012
Waltham, Massachusetts-based QuantiaMD, which offers a mobile and online physician community and collaboration platform, raised a $12 million round of funding from return backer Fuse Capital. The company plans to use the funds for building out its platform's capabilities and better meet the needs of payers, health systems, and others who leverage QuantiaMD to engage with physicians. It will also...